$PETV
PetVivo Holdings, Inc.

2024 Q4 Form 10-Q Financial Statement

#000149315224045778 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $200.7K
YoY Change -3.2%
Cost Of Revenue $21.16K
YoY Change -84.98%
Gross Profit $179.6K
YoY Change 170.2%
Gross Profit Margin 89.46%
Selling, General & Admin $1.887M
YoY Change -31.87%
% of Gross Profit 1051.15%
Research & Development $465.2K
YoY Change 93.6%
% of Gross Profit 259.07%
Depreciation & Amortization $31.66K
YoY Change 5.26%
% of Gross Profit 17.63%
Operating Expenses $2.353M
YoY Change -21.86%
Operating Profit -$2.173M
YoY Change -26.2%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$2.453K
YoY Change -99.66%
Pretax Income -$2.175M
YoY Change -40.58%
Income Tax
% Of Pretax Income
Net Earnings -$2.175M
YoY Change -40.58%
Net Earnings / Revenue -1083.84%
Basic Earnings Per Share -$0.11
Diluted Earnings Per Share -$0.11
COMMON SHARES
Basic Shares Outstanding 20.86M shares 20.00M shares
Diluted Shares Outstanding 20.10M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $126.2K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $372.1K
Prepaid Expenses
Receivables $133.7K
Other Receivables
Total Short-Term Assets $1.246M
YoY Change -38.17%
LONG-TERM ASSETS
Property, Plant & Equipment $777.3K
YoY Change 16.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.940M
YoY Change -5.16%
TOTAL ASSETS
Total Short-Term Assets $1.246M
Total Long-Term Assets $1.940M
Total Assets $3.187M
YoY Change -21.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $762.1K
YoY Change -16.44%
Accrued Expenses $395.6K
YoY Change -51.66%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.858M
YoY Change -2.99%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $919.6K
YoY Change -20.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.858M
Total Long-Term Liabilities $919.6K
Total Liabilities $2.778M
YoY Change -9.62%
SHAREHOLDERS EQUITY
Retained Earnings -$87.02M
YoY Change 11.0%
Common Stock $20.07K
YoY Change 44.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $409.2K
YoY Change
Total Liabilities & Shareholders Equity $3.187M
YoY Change -21.54%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$2.175M
YoY Change -40.58%
Depreciation, Depletion And Amortization $31.66K
YoY Change 5.26%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
653103 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1691790 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2500378 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2352598 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
dei Entity Central Index Key
EntityCentralIndexKey
0001512922
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40715
dei Entity Registrant Name
EntityRegistrantName
PetVivo Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0363559
dei Entity Address Address Line1
EntityAddressAddressLine1
5151 Edina Industrial
dei Entity Address Address Line2
EntityAddressAddressLine2
Blvd Suite 575
dei Entity Address City Or Town
EntityAddressCityOrTown
Edina
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55439
dei City Area Code
CityAreaCode
(952)
dei Local Phone Number
LocalPhoneNumber
405-6216
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126239 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87403 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
133680 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18669 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
372115 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
390076 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
614350 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
545512 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1246384 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1041660 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
777330 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
821656 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1101557 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1194348 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26483 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30099 usd
CY2024Q3 us-gaap Security Deposit
SecurityDeposit
34990 usd
CY2024Q1 us-gaap Security Deposit
SecurityDeposit
27490 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
1163030 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
1251937 usd
CY2024Q3 us-gaap Assets
Assets
3186744 usd
CY2024Q1 us-gaap Assets
Assets
3115253 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
762103 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
821230 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
395625 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
243030 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
191373 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
190589 usd
CY2024Q3 PETV Notes Payable And Accrued Interest Current
NotesPayableAndAccruedInterestCurrent
508916 usd
CY2024Q1 PETV Notes Payable And Accrued Interest Current
NotesPayableAndAccruedInterestCurrent
157521 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1412370 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
910184 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1003759 usd
CY2024Q3 PETV Notes Payable And Accrued Interest Non Current
NotesPayableAndAccruedInterestNonCurrent
9372 usd
CY2024Q1 PETV Notes Payable And Accrued Interest Non Current
NotesPayableAndAccruedInterestNonCurrent
13171 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
919556 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1016930 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2777573 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2429300 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20067164 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17058620 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17058620 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
20067 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
17059 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2024Q1 PETV Common Stock To Be Issued
CommonStockToBeIssued
usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2024Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q3 PETV Stock Issued During Period Value Cashless Warrants Exercises
StockIssuedDuringPeriodValueCashlessWarrantsExercises
usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2017Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P84M
CY2024Q3 PETV Base Rent Payments Included In Prepaid Expenses
BaseRentPaymentsIncludedInPrepaidExpenses
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20857164 shares
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1858017 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20067164 shares
CY2024Q3 PETV Common Stock To Be Issued
CommonStockToBeIssued
132000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
87275939 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
83468218 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87021880 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82799324 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
409171 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
685953 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3186744 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3115253 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
200720 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
207366 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
324470 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
324549 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21162 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21862 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34156 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34167 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
179558 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
185504 usd
us-gaap Gross Profit
GrossProfit
290314 usd
us-gaap Gross Profit
GrossProfit
290382 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
620307 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1078725 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1154720 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2020611 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
465174 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
359332 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
852689 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1267117 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3454588 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3129847 usd
us-gaap Operating Expenses
OperatingExpenses
4507787 usd
us-gaap Operating Expenses
OperatingExpenses
6128302 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2173040 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2944343 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4217473 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5837920 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-534366 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-534366 usd
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
180000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
180000 usd
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2453 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2444 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5083 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2444 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2453 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-716810 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5083 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-716810 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2175493 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3661153 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4222556 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6554730 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2175493 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3661153 usd
us-gaap Net Income Loss
NetIncomeLoss
-4222556 usd
us-gaap Net Income Loss
NetIncomeLoss
-6554730 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20099095 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20099095 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12987641 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12987641 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19395401 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19395401 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12325973 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12325973 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
685953 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1322600 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
301558 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
214160 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
352295 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2047063 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
829503 usd
CY2024Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1218000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
56020 usd
CY2024Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
132000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
349141 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2175493 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
409171 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
725025 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1956094 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
123078 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
413030 usd
CY2023Q2 PETV Stock Issued During Period Value Vesting Of Restricted Stock Units In Lieu Of Compensation
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnitsInLieuOfCompensation
74589 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2893577 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
398239 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
398239 usd
CY2023Q3 PETV Stock Issued During Period Value Common Stock And Warrants Sold
StockIssuedDuringPeriodValueCommonStockAndWarrantsSold
1775782 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
740978 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
577500 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
509310 usd
CY2023Q3 PETV Stock Issued During Period Value Vesting Of Restricted Stock Units In Lieu Of Compensation
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnitsInLieuOfCompensation
41006 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
607017 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3661153 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
988679 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
988679 usd
us-gaap Net Income Loss
NetIncomeLoss
-4222556 usd
us-gaap Net Income Loss
NetIncomeLoss
-6554730 usd
us-gaap Share Based Compensation
ShareBasedCompensation
701436 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1020047 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66540 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63364 usd
PETV Consulting And Investor Relations Services Paid In Stock
ConsultingAndInvestorRelationsServicesPaidInStock
315088 usd
PETV Consulting And Investor Relations Services Paid In Stock
ConsultingAndInvestorRelationsServicesPaidInStock
403326 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
132000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
115595 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-534366 usd
us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
2900 usd
us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
2444 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
121247 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
418180 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
115011 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
69199 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17961 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
63797 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
92127 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
361802 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3130762 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4604962 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18598 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
93618 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18598 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-93618 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1322600 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3731876 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1218000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
150000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
550000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2404 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3356 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3188196 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4278520 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
38836 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-420060 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
87403 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
475314 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
126239 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
55254 usd
us-gaap Interest Paid Net
InterestPaidNet
5084 usd
us-gaap Interest Paid Net
InterestPaidNet
846 usd
PETV Convertible Debentures And Accrued Interest Converted To Common Stock
ConvertibleDebenturesAndAccruedInterestConvertedToCommonStock
301558 usd
PETV Convertible Debentures And Accrued Interest Converted To Common Stock
ConvertibleDebenturesAndAccruedInterestConvertedToCommonStock
577500 usd
PETV Stock Granted For Consulting Services
StockGrantedForConsultingServices
210100 usd
PETV Stock Granted For Consulting Services
StockGrantedForConsultingServices
626540 usd
PETV Decrease Increase To Operating Lease Right Of Use Asset And Operating Lease Liability
DecreaseIncreaseToOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
-92792 usd
PETV Decrease Increase To Operating Lease Right Of Use Asset And Operating Lease Liability
DecreaseIncreaseToOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
1081204 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zy7mR33lC9jg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(D) <span id="xdx_860_zNrF5CK79fle">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include collectability of accounts receivable, inventory obsolescence, estimated useful lives and potential impairment of property and equipment and intangibles, estimate of fair value of share-based payments, distributor rebate payable, provision for product returns, right of use lease assets and liabilities and valuation of deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zEghCgKFoaH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(F) <span id="xdx_864_zKC1l1jmexH3">Concentration Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash with various financial institutions, which at times may exceed federally insured limits. At September 30, 2024, the Company did not have cash balances in excess of the federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Inventory Adjustments
InventoryAdjustments
0 usd
CY2023Q3 us-gaap Inventory Adjustments
InventoryAdjustments
0 usd
PETV Distribution Fee Payable Percentage
DistributionFeePayablePercentage
0.05 pure
CY2024Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
133380 usd
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
18669 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
57264 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
57264 usd
CY2024Q3 PETV Distribution Fee Payable
DistributionFeePayable
9250 usd
CY2024Q1 PETV Distribution Fee Payable
DistributionFeePayable
7583 usd
CY2024Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
0 usd
CY2024Q1 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
0 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
372115 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
390076 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12303 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35442 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
57511 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
20289 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
302301 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
334345 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
372115 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
390076 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
614350 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
545512 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1267844 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1249246 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
490514 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
427590 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
777330 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
821656 usd
CY2024Q3 us-gaap Depreciation
Depreciation
31661 usd
CY2023Q3 us-gaap Depreciation
Depreciation
30078 usd
us-gaap Depreciation
Depreciation
62924 usd
us-gaap Depreciation
Depreciation
59089 usd
CY2024Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3870057 usd
CY2024Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3870057 usd
CY2024Q3 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
26142 usd
CY2024Q1 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
26142 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3896199 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3896199 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3869716 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3866100 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26483 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30099 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1382 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2137 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3616 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4275 usd
CY2024Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
214765 usd
CY2024Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
111353 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
180860 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
131677 usd
CY2024Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
395625 usd
CY2024Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
243030 usd
CY2020Q1 us-gaap Notes Payable
NotesPayable
42500 usd
CY2020Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.06 pure
CY2024Q3 us-gaap Notes Payable
NotesPayable
16857 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
20528 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
7485 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9372 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
7521 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13171 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
120000 usd
CY2023Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.10 pure
CY2023Q4 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
February 2024
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.75
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
123255 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
164340 shares
CY2024Q3 us-gaap Notes Payable
NotesPayable
350000 usd
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
25463 usd
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
25408 usd
CY2017Q2 us-gaap Area Of Land
AreaOfLand
3577 sqft
CY2017Q2 PETV Percentage Of Increase In Rent
PercentageOfIncreaseInRent
0.02 pure
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
139225 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
226166 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
179916 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
114410 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
114273 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
117228 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
401289 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1292507 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
190950 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1101557 usd
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
the extended lease terms to June 2026, November 7, 2026, March 2027, and June 2033
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0419 pure
CY2024Q3 PETV Operating Lease Liability Gross
OperatingLeaseLiabilityGross
1101557 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1101557 usd
CY2024Q3 PETV Operating Lease Rightofuse Current Asset
OperatingLeaseRightofuseCurrentAsset
1101557 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1101557 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
191373 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
910184 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1101557 usd
us-gaap Net Income Loss
NetIncomeLoss
-4222556 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3130762 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87021880 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3338544 shares
CY2024Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1889434 shares
CY2024Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1889434 shares
CY2024Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1322600 usd
CY2024Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1322600 usd
CY2024Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.70
CY2024Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.70
CY2024Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
430798 shares
CY2024Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
301558 usd
CY2024Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.70
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2891511 shares
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
793585 shares
CY2023Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2182359 usd
CY2023Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
88765 usd
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.75
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
137500 usd
CY2023Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1200002 shares
CY2023Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1775782 usd
CY2023Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
24218 usd
CY2023Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.50
PETV Amortization Of Stock Issued For Services
AmortizationOfStockIssuedForServices
315088 usd
PETV Amortization Of Stock Issued For Services
AmortizationOfStockIssuedForServices
403326 usd
PETV Prepaid Stock Issued For Services
PrepaidStockIssuedForServices
100928 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.782 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.105 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.759 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.957 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0147 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0435 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0346 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0452 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
884849 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.19
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
100200 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
822605 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.77
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
198332 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.03
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1509122 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.98
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
122000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
636080 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.06
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
995042 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y2M12D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
310742 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
936707 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
709394 shares
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
684300 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
936707 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
310742 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
572415 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.84
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.23
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.57
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.84
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2.31
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.87
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
2.03
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
701436 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1135642 usd

Files In Submission

Name View Source Status
0001493152-24-045778-index-headers.html Edgar Link pending
0001493152-24-045778-index.html Edgar Link pending
0001493152-24-045778.txt Edgar Link pending
0001493152-24-045778-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
petv-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
petv-20240930_cal.xml Edgar Link unprocessable
petv-20240930_def.xml Edgar Link unprocessable
petv-20240930_lab.xml Edgar Link unprocessable
petv-20240930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable